Skip to main content

Table 4 Prevention for perinatal GBS disease among mothers of infected/colonized neonates and colonized pregnant women

From: Phenotypic and genetic differences among group B Streptococcus recovered from neonates and pregnant women in Shenzhen, China: 8-year study

Parameter

No. of cases

MEOC

MLOC

MCN

CPWa

Vaginal delivery

9 (12)b

11 (16)

9 (11)

19 (47)

Cesarean delivery

3 (12)

5 (16)

2 (11)

28 (47)

Full term labor

11 (12)

16 (17)

5 (11)

13 (47)

Preterm labor

1 (12)

1 (17)

6 (11)

34 (47)

PROM ≥ 18 h

3 (11)

0 (9)

1 (11)

21 (47)

PROM < 18 h

1 (11)

2 (9)

1 (11)

8 (47)

Without PROM

7 (11)

7 (9)

9 (11)

18 (47)

Screening for GBS prior to labor

1c (9)

0 (9)

4d (11)

46e (47)

Obtaining GBS culture results prior to labor

1 (9)

0 (9)

1 (11)

29 (47)

Without IAP at onset of true labor

8 (9)

9 (9)

8 (11)

13f (47)

Correct IAP at onset of true laborg

0 (9)

0 (9)

0 (11)

0 (47)

Incorrect IAP at onset of true labor

1 (9)

0 (9)

3 (11)

34 (47)

 Incorrect dosing

0 (1)

1 (3)

17 (34)

 Incorrect dosing and timing

1 (1)

1 (3)

15 (34)

 Non-recommended drugsh

0 (1)

1 (3)

2 (34)

 Non-recommended drugs and incorrect timing

0 (1)

0 (3)

0 (34)

  1. MEOC mother of early-onset case MLOC mother of late-onset case MCN mother of colonized neonate CPW colonized pregnant woman PROM premature rupture of membranes – none
  2. a Except mothers of infected/colonized neonates
  3. b Parentheses refer to the total of cases with available data
  4. c One case with threatened preterm labor
  5. d Four cases with preterm labor
  6. e Including 34 cases of preterm labor
  7. f Including 10 cases with unknown GBS status at the onset of labor
  8. g According to the 2010 guidelines recommended by CDC
  9. h Including erythromycin